On the heels of un­prompt­ed EMA re­view of Covid drug, FDA sched­ules ad­comm for po­ten­tial EUA

The FDA is now fol­low­ing through on an emer­gency use fil­ing for a re­pur­posed can­cer drug that Eu­ro­pean reg­u­la­tors ini­tial­ly took an in­ter­est in. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.